Volume 64, Issue 2, Pages (August 2003)

Slides:

Advertisements

Similar presentations

Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Giuseppe D’Amico Kidney International Volume 54, Issue 2, Pages

Advertisements

Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy Francesco Paolo Schena Kidney International Volume 57,

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.

E. Cavalier, P. Delanaye, A. Carlisi, J. -M. Krzesinski, J. -P

Volume 67, Pages S1-S7 (June 2005)

FGF-23 in patients with end-stage renal disease on hemodialysis

Volume 55, Issue 3, Pages (March 1999)

Anemia management in chronic kidney disease

Mitchell H. Rosner, W. Kline Bolton Kidney International

Volume 83, Issue 3, Pages (March 2013)

Volume 63, Issue 6, Pages (June 2003)

Vitamin D deficiency and heart disease

Kidney transplantation in a low-resource setting: Nigeria experience

Reassessment of the care of the patient with chronic kidney disease

M. Fukagawa, S. Nakanishi, J.J. Kazama Kidney International

Burden of chronic kidney disease: North Africa

Francesco Paolo Schena Kidney International

Volume 76, Pages S50-S99 (August 2009)

Comorbidity and confounding in end-stage renal disease

Acute myocardial infarction in patients with chronic kidney disease: how are the most vulnerable patients doing? Gautam R. Shroff, Charles A. Herzog

Volume 74, Issue 3, Pages (August 2008)

Lipid redistribution in renal dysfunction

Volume 70, Issue 11, Pages (December 2006)

Volume 79, Pages S20-S23 (April 2011)

The epidemiology of chronic kidney disease

Use of vitamin D in chronic kidney disease patients

Florian Lang, Michael Föller Kidney International

Volume 95, Issue 2, Pages (February 2019)

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Elke Wühl, Otto Mehls, Franz Schaefer Kidney International

Volume 59, Issue 4, Pages (April 2001)

Volume 76, Issue 5, Pages (September 2009)

FGF-23 in patients with end-stage renal disease on hemodialysis

Fructose intake as a risk factor for kidney stone disease

Response to ‘Hepcidin levels in patients with renal disease’

American Journal of Kidney Diseases

Volume 76, Issue 6, Pages (September 2009)

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Elevated risk of stroke among patients with end-stage renal disease

Volume 87, Issue 3, Pages (March 2015)

Volume 68, Issue 3, Pages (September 2005)

Atrial fibrillation in end-stage renal disease: an emerging problem

Quiz Page August 2007 American Journal of Kidney Diseases

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Volume 81, Issue 9, Pages (May 2012)

Volume 78, Issue 4, Pages (August 2010)

Fibroblast growth factor 23: the making of a hormone

Volume 54, Issue 2, Pages (August 1998)

Volume 73, Issue 6, Pages (March 2008)

Volume 54, Issue 1, Pages (July 1998)

Volume 56, Issue 3, Pages (September 1999)

Low triiodothyronine and survival in end-stage renal disease

Pablo A. Ureña Torres, Marc De Broe Kidney International

Quiz page answers August 2003

Volume 80, Issue 10, Pages (November 2011)

Is complement a target for therapy in renal disease?

Volume 70, Issue 3, Pages (August 2006)

Stephen G. Rostand, Tilman B. Drüeke Kidney International

Volume 70, Issue 5, Pages (September 2006)

Volume 70, Issue 10, Pages (November 2006)

Increased fetuin-A levels following treatment with a vitamin D analog

Familial phenotype differences in PKD11

Volume 74, Issue 10, Pages (November 2008)

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Volume 86, Issue 2, Pages (August 2014)

Volume 64, Pages S131-S136 (November 2003)

Presentation transcript:

Volume 64, Issue 2, Pages 737-742 (August 2003) Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease B. Peter Sawaya, Rezkalla Butros, Shehzab Naqvi, Zhaopo Geng, Hanna Mawad, Robert Friedler, Paolo Fanti, Marie-Claude Monier- Faugere, Hartmut H. Malluche Kidney International Volume 64, Issue 2, Pages 737-742 (August 2003) DOI: 10.1046/j.1523-1755.2003.00129.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Correlation between intact parathyroid hormone and activation frequency in (A) Caucasians (r = 0.60, P < 0.01), and (B) African Americans (r = 0.22, P = NS). Kidney International 2003 64, 737-742DOI: (10.1046/j.1523-1755.2003.00129.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Intact parathyroid hormone (PTH) in African-Americans (AA) and Caucasians (C) with low and high bone turnover (BT).*P < 0.01 compared to PTH levels in all other groups. Kidney International 2003 64, 737-742DOI: (10.1046/j.1523-1755.2003.00129.x) Copyright © 2003 International Society of Nephrology Terms and Conditions